← All trials
NCT02062684
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2013
- Primary completion
- Mar 1, 2017
- Completion date
- May 31, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 57
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Anthera PharmaceuticalsLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.